Visualization of naturally occurring Foxp3+ regulatory T cells in normal and tumor-bearing mice

International Immunopharmacology

Volumn 4, Issue 14 SPEC.ISS., 2004, Pages 1785-1793

  Hontsu, Shigeto ^a,b   Yoneyama, Hiroyuki ^a   Ueha, Satoshi ^a   Terashima, Yuya ^a   Kitabatake, Masahiro ^a   Nakano, Akiko ^a   Ito, Toshihiro ^a,b   Kimura, Hiroshi ^b   Matsushima, Kouji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Lymph nodes; Spleen; T lymphocytes; Transcription factors; Tumor immunity

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN P 15095; POLYCLONAL ANTIBODY; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY T LYMPHOCYTE; SPLEEN; T LYMPHOCYTE;

EID: 8644247413     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.07.026     Document Type: Conference Paper

References (26)

1. S. Sakaguchi, N. Sakaguchi, J. Shimizu, S. Yamazaki, T. Sakihama, and M. Itoh Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance Immunol. Rev. 182 2001 18
2. P.A. Taylor, R.J. Noelle, and B.R. Blazar CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade J. Exp. Med. 193 2001 1311
3. Y. Belkaid, C.A. Piccirillo, S. Mendez, E.M. Shevach, and D.L. Sacks CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity Nature 420 2002 502
4. S. Onizuka, I. Tawara, J. Shimizu, S. Sakaguchi, T. Fujita, and E. Nakayama Tumor rejection by in vivo administration of antiCD25 (interleukin-2 receptor alpha) monoclonal antibody Cancer Res. 59 1999 3228
5. J. Shimizu, S. Yamazaki, and S. Sakaguchi Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity J. Immunol. 163 1999 5211
6. A.M. Wolf, D. Wolf, M. Steurer, G. Gastl, E. Gunsilius, and B. Grubeck-Loebenstein Increase of regulatory T cells in the peripheral blood of cancer patients Clin. Cancer Res. 9 2003 606
7. F. Ichihara, K. Kono, A. Takahashi, H. Kawaida, H. Sugai, and H. Fujii Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers Clin. Cancer Res. 9 2003 4404
8. J.A. Bluestone, and A.K. Abbas Natural versus adaptive regulatory T cells Nat. Rev., Immunol. 3 2003 253
9. A.M. Thornton, and E.M. Shevach CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production J. Exp. Med. 188 1998 287
10. E.M. Shevach CD4+CD25+ suppressor T cells: more questions than answers Nat. Rev., Immunol. 2 2002 389
11. H. Liu, B. Hu, D. Xu, and F.Y. Liew CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4 J. Immunol. 171 2003 5012
12. C.I. Kingsley, M. Karim, A.R. Bushell, and K.J. Wood CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of allo responses J. Immunol. 168 2002 1080
13. S. Hori, T. Nomura, and S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 2003 1057
14. J.D. Fontenot, M.A. Gavin, and A.Y. Rudensky Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nat. Immunol. 4 2003 330
15. R. Khattri, T. Cox, S.A. Yasayko, and F. Ramsdell An essential role for Scurfin in CD4+CD25+ T regulatory cells Nat. Immunol. 4 2003 337
16. R.S. McHugh, M.J. Whitters, C.A. Piccirillo, D.A. Young, E.M. Shevach, and M. Collins CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor Immunity 16 2002 311
17. J. Shimizu, S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance Nat. Immunol. 3 2002 135
18. T. Takahashi, T. Tagami, S. Yamazaki, T. Uede, J. Shimizu, and N. Sakaguchi Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4 J. Exp. Med. 192 2000 303
19. P. Bansal-Pakala, A.G. Jember, and M. Croft Signaling through OX40 (CD134)breaks peripheral T-cell tolerance Nat. Med. 7 2001 907
20. M.E. Brunkow, E.W. Jeffery, K.A. Hjerrild, B. Paeper, L.B. Clark, and S.A. Yasayko Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse Nat. Genet. 27 2001 68
21. B. Wang, D. Lin, C. Li, and P. Tucker Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors J. Biol. Chem. 278 2003 24259
22. M.M. Lu, S. Li, H. Yang, and E.E. Morrisey Foxp4: a novel member of the Foxp subfamily of winged-helix genes co-expressed with Foxp1 and Foxp2 in pulmonary and gut tissues Gene Expr. Patterns 2 2002 223
23. C.A. Piccirillo, and E.M. Shevach Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells J. Immunol. 167 2001 1137
24. C. Mottet, H.H. Uhlig, and F. Powrie Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells J. Immunol. 170 2003 3939
25. H. Nishikawa, T. Kato, K. Tanida, A. Hiasa, I. Tawara, and H. Ikeda CD4+CD25+Tcells responding to serologically defined autoantigens suppress antitumor immune responses Proc. Natl. Acad. Sci. U. S. A. 100 2003 10902
26. S. Yamazaki, T. Iyoda, K. Tarbell, K. Olson, K. Velinzon, and K. Inaba Direct expansion of functional CD25+CD4+ regulatory T cells by antigen-processing dendritic cells J. Exp. Med. 171 2003 5012